» Articles » PMID: 24803507

Early Life Triclocarban Exposure During Lactation Affects Neonate Rat Survival

Overview
Journal Reprod Sci
Publisher Springer
Date 2014 May 8
PMID 24803507
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Triclocarban (3,4,4'-trichlorocarbanilide; TCC), an antimicrobial used in bar soaps, affects endocrine function in vitro and in vivo. This study investigates whether TCC exposure during early life affects the trajectory of fetal and/or neonatal development. Sprague Dawley rats were provided control, 0.2% weight/weight (w/w), or 0.5% w/w TCC-supplemented chow through a series of 3 experiments that limited exposure to critical growth periods: gestation, gestation and lactation, or lactation only (cross-fostering) to determine the susceptible windows of exposure for developmental consequences. Reduced offspring survival occurred when offspring were exposed to TCC at concentrations of 0.2% w/w and 0.5% w/w during lactation, in which only 13% of offspring raised by 0.2% w/w TCC dams survived beyond weaning and no offspring raised by 0.5% w/w TCC dams survived to this period. In utero exposure status had no effect on survival, as all pups nursed by control dams survived regardless of their in utero exposure status. Microscopic evaluation of dam mammary tissue revealed involution to be a secondary outcome of TCC exposure rather than a primary effect of compound administration. The average concentration of TCC in the milk was almost 4 times that of the corresponding maternal serum levels. The results demonstrate that gestational TCC exposure does not affect the ability of dams to carry offspring to term but TCC exposure during lactation has adverse consequences on the survival of offspring although the mechanism of reduced survival is currently unknown. This information highlights the importance of evaluating the safety of TCC application in personal care products and the impacts during early life exposure.

Citing Articles

Advances in understanding the reproductive toxicity of endocrine-disrupting chemicals in women.

Wang J, Zhao C, Feng J, Sun P, Zhang Y, Han A Front Cell Dev Biol. 2024; 12:1390247.

PMID: 38606320 PMC: 11007058. DOI: 10.3389/fcell.2024.1390247.


Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction.

Jozkowiak M, Piotrowska-Kempisty H, Kobylarek D, Gorska N, Mozdziak P, Kempisty B Cells. 2023; 12(1).

PMID: 36611967 PMC: 9818374. DOI: 10.3390/cells12010174.


Prenatal Exposure to Triclocarban Impairs ESR1 Signaling and Disrupts Epigenetic Status in Sex-Specific Ways as Well as Dysregulates the Expression of Neurogenesis- and Neurotransmitter-Related Genes in the Postnatal Mouse Brain.

Wnuk A, Rzemieniec J, Przepiorska K, Pietrzak B, Mackowiak M, Kajta M Int J Mol Sci. 2021; 22(23).

PMID: 34884933 PMC: 8658534. DOI: 10.3390/ijms222313121.


Antibacterial soap use impacts skin microbial communities in rural Madagascar.

Yu J, Manus M, Mueller O, Windsor S, Horvath J, Nunn C PLoS One. 2018; 13(8):e0199899.

PMID: 30125279 PMC: 6101359. DOI: 10.1371/journal.pone.0199899.


Triclocarban Disrupts the Epigenetic Status of Neuronal Cells and Induces AHR/CAR-Mediated Apoptosis.

Kajta M, Wnuk A, Rzemieniec J, Lason W, Mackowiak M, Chwastek E Mol Neurobiol. 2018; 56(5):3113-3131.

PMID: 30097849 PMC: 6476872. DOI: 10.1007/s12035-018-1285-4.


References
1.
Zhao J, Ying G, Liu Y, Chen F, Yang J, Wang L . Occurrence and risks of triclosan and triclocarban in the Pearl River system, South China: from source to the receiving environment. J Hazard Mater. 2010; 179(1-3):215-22. DOI: 10.1016/j.jhazmat.2010.02.082. View

2.
Neville M, WALSH C . Effects of xenobiotics on milk secretion and composition. Am J Clin Nutr. 1995; 61(3 Suppl):687S-694S. DOI: 10.1093/ajcn/61.3.687S. View

3.
Chung E, Genco M, Megrelis L, Ruderman J . Effects of bisphenol A and triclocarban on brain-specific expression of aromatase in early zebrafish embryos. Proc Natl Acad Sci U S A. 2011; 108(43):17732-7. PMC: 3203771. DOI: 10.1073/pnas.1115187108. View

4.
Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I . Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12(2):106-11. DOI: 10.1097/01.MIB.0000200323.38139.c6. View

5.
Donskey C . The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis. 2004; 39(2):219-26. DOI: 10.1086/422002. View